GlassScriptPhysician profile
Amber R Cooper
NPI 1871632364
$78,945.43
in general payments reported to CMS, 2019-2025
10 companies · $11K in 2025
The $11K reported for 2025 was more than what 97% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,508 · 2020: $4,578 · 2021: $9,522 · 2022: $15K · 2023: $24K · 2024: $5,875 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Consulting Fee: $7,760 · Travel and Lodging: $2,439 · Food and Beverage: $1,484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29,585.00 |
| Consulting Fee | $7,760.00 |
| Travel and Lodging | $2,439.44 |
| Food and Beverage | $1,483.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $70,093.78 | 2019-2025 | Menopur |
| Coopersurgical, INC. | $5,901.57 | 2019-2025 | Stripper, Origio Sequential Fert |
| Ge Healthcare | $1,940.00 | 2019 | |
| Emd Serono, INC. | $366.78 | 2019-2024 | |
| Organon LLC | $346.43 | 2021-2025 | Ganirelix Acetate, Follistim Aq |
| Merck Sharp & Dohme LLC | $178.17 | 2019-2021 | |
| Covidien LP | $52.60 | 2019 | |
| Galen US INC | $24.34 | 2021 | |
| Hologic Sales and Service, LLC | $24.12 | 2024 | Third Wave, Aptima, Thinprep 2000 Processor |
| Cook Medical LLC | $17.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.